First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy
Munster, Pamela, Mita, Monica, Mahipal, Amit, Nemunaitis, John, Massard, Christophe, Mikkelsen, Tom, Cruz, Cristina, Paz-Ares, Luis, Hidalgo, Manuel, Rathkopf, Dana, Blumenschein, Jr, George, Smith, David C, Eichhorst, Barbara, Cloughesy, Tim, Filvaroff, Ellen H, Li, Shaoyi, Raymon, Heather, de Haan, Hans, Hege, Kristen, Bendell, Johanna C
Published in Cancer management and research (01.12.2019)
Published in Cancer management and research (01.12.2019)
Get full text
Journal Article
Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer
HERBST, Roy S, JOHNSON, David H, HONG, Waun K, TRAN, Hai, TSAO, Anne, DONG XIE, RAMIES, David A, MASS, Robert, SESHAGIRI, Somasekar, EBERHARD, David A, KELLEY, Sean K, SANDLER, Alan, MININBERG, Eric, CARBONE, David P, HENDERSON, Ted, KIM, Edward S, BLUMENSCHEIN, George JR, LEE, Jack J, LIU, Diane D, TRUONG, Mylene T
Published in Journal of clinical oncology (10.04.2005)
Published in Journal of clinical oncology (10.04.2005)
Get full text
Journal Article
Conference Proceeding
Emerging therapeutic strategies for enhancing sensitivity and countering resistance to programmed cell death protein 1 or programmed death‐ligand 1 inhibitors in non–small cell lung cancer
Villaruz, Liza C., Blumenschein, George R., Otterson, Gregory A., Leal, Ticiana A.
Published in Cancer (01.05.2023)
Published in Cancer (01.05.2023)
Get full text
Journal Article
Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC
Hong, Lingzhi, Negrao, Marcelo V., Dibaj, Seyedeh S., Chen, Runzhe, Reuben, Alexandre, Bohac, Jadi M., Liu, Xiaoke, Skoulidis, Ferdinandos, Gay, Carl M., Cascone, Tina, Mitchell, Kyle G., Tran, Hai T., Le, Xiuning, Byers, Lauren A., Sepesi, Boris, Altan, Mehmet, Elamin, Yasir Y., Fossella, Frank V., Kurie, Jonathan M., Lu, Charles, Mott, Frank E., Tsao, Anne S., Rinsurongkawong, Waree, Lewis, Jeff, Gibbons, Don L., Glisson, Bonnie S., Blumenschein, George R., Roarty, Emily B., Futreal, P. Andrew, Wistuba, Ignacio I., Roth, Jack A., Swisher, Stephen G., Papadimitrakopoulou, Vassiliki A., Heymach, John V., Lee, J. Jack, Simon, George R., Zhang, Jianjun
Published in Journal of thoracic oncology (01.09.2020)
Published in Journal of thoracic oncology (01.09.2020)
Get full text
Journal Article
Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial
Hui, David, Puac, Veronica, Shelal, Zeena, Dev, Rony, Hanneman, Sandra K, Jennings, Kristofer, Ma, Hilary, Urbauer, Diana L, Shete, Sanjay, Fossella, Frank, Liao, Zhongxing, Blumenschein, George, Chang, Joe Y, O'Reilly, Michael, Gandhi, Saumil J, Tsao, Anne, Mahler, Donald A, Bruera, Eduardo
Published in The lancet oncology (01.10.2022)
Published in The lancet oncology (01.10.2022)
Get full text
Journal Article
Nivolumab versus investigator’s choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age
Saba, Nabil F., Blumenschein, George, Guigay, Joel, Licitra, Lisa, Fayette, Jerome, Harrington, Kevin J., Kiyota, Naomi, Gillison, Maura L., Ferris, Robert L., Jayaprakash, Vijayvel, Li, Li, Brossart, Peter
Published in Oral oncology (01.09.2019)
Published in Oral oncology (01.09.2019)
Get full text
Journal Article
Targeting the Hepatocyte Growth Factor–cMET Axis in Cancer Therapy
BLUMENSCHEIN, George R, MILLS, Gordon B, GONZALEZ-ANGULO, Ana M
Published in Journal of clinical oncology (10.09.2012)
Published in Journal of clinical oncology (10.09.2012)
Get full text
Journal Article
Phase II study of gefitinib in patients with advanced salivary gland cancers
Jakob, John A., Kies, Merrill S., Glisson, Bonnie S., Kupferman, Michael E., Liu, Diane D., Lee, J. Jack, El-Naggar, Adel K., Gonzalez-Angulo, Ana M., Blumenschein Jr, George R.
Published in Head & neck (01.05.2015)
Published in Head & neck (01.05.2015)
Get full text
Journal Article
Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer
KARP, Daniel D, PAZ-ARES, Luis G, JOHNSON, Faye M, GREEN, Stephanie, GUALBERTO, Antonio, NOVELLO, Silvia, HALUSKA, Paul, GARLAND, Linda, CARDENAL, Felipe, JOHNETTA BLAKELY, L, EISENBERG, Peter D, LANGER, Corey J, BLUMENSCHEIN, George
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
SPIGEL, David R, ERVIN, Thomas J, GOVINDAN, Ramaswamy, PATEL, Taral, ORLOV, Sergey V, WERTHEIM, Michael S, WEI YU, JIPING ZHA, YAUCH, Robert L, PATEL, Premal H, PHAN, See-Chun, PETERSON, Amy C, RAMLAU, Rodryg A, DANIEL, Davey B, GOLDSCHMIDT, Jerome H, BLUMENSCHEIN, George R, KRZAKOWSKI, Maciej J, ROBINET, Gilles, GODBERT, Benoit, BARLESI, Fabrice
Published in Journal of clinical oncology (10.11.2013)
Published in Journal of clinical oncology (10.11.2013)
Get full text
Journal Article
Conference Proceeding
A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Razak, Albiruni R. Abdul, Wang, Hung-Ming, Chang, Jang-Yang, Ahn, Myung-Ju, Munster, Pamela, Blumenschein, George, Solomon, Benjamin, Lim, Darren Wan-Teck, Hong, Ruey-Long, Pfister, David, Saba, Nabil F., Lee, Se-Hoon, van Herpen, Carla, Quadt, Cornelia, Bootle, Douglas, Blumenstein, Lars, Demanse, David, Delord, Jean-Pierre
Published in Targeted oncology (01.11.2023)
Published in Targeted oncology (01.11.2023)
Get full text
Journal Article
Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non–Small-Cell Lung Cancer: RTOG 0324
BLUMENSCHEIN, George R, PAULUS, Rebecca, CURRAN, Walter J, ROBERT, Francisco, FOSSELLA, Frank, WERNER-WASIK, Maria, HERBST, Roy S, DOESCHER, Philip O, CHOY, Hak, KOMAKI, Ritsuko
Published in Journal of clinical oncology (10.06.2011)
Published in Journal of clinical oncology (10.06.2011)
Get full text
Journal Article
Phase II, Multicenter, Uncontrolled Trial of Single-Agent Sorafenib in Patients With Relapsed or Refractory, Advanced Non–Small-Cell Lung Cancer
BLUMENSCHEIN, George R, GATZEMEIER, Ulrich, FOSSELLA, Frank, STEWART, David J, CUPIT, Lisa, CIHON, Frank, O'LEARY, James, RECK, Martin
Published in Journal of clinical oncology (10.09.2009)
Published in Journal of clinical oncology (10.09.2009)
Get full text
Journal Article
Conference Proceeding
959 Safety and anti-tumor activity of TCR-engineered autologous, PRAME-directed T cells across multiple advanced solid cancers at low doses – clinical update on the ACTengine® IMA203 trial
Wermke, Martin, Tsimberidou, Apostolia-Maria, Mohamed, Ali, Mayer-Mokler, Andrea, Satelli, Arun, Reinhardt, Carsten, Araujo, Dejka, Maurer, Dominik, Blumenschein, George Jr, Singh, Harpreet, Luke, Jason, Guenther, Kerstin, Kalra, Mamta, Chatterjee, Manik, Hilf, Norbert, Mendrzyk, Regina, Walter, Steffen, Eck, Stephen, Holderried, Tobias AW, Weinschenk, Toni, Morris, Van, Alsdorf, Winfried, Britten, Cedrik M
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients
Wang, Tianjiao, Navenot, Jean-Marc, Rafail, Stavros, Kurtis, Cynthia, Carroll, Mark, Van Kerckhoven, Marian, Van Rossom, Sofie, Schats, Kelly, Avraam, Konstantinos, Broad, Robyn, Howe, Karen, Liddle, Ashley, Clayton, Amber, Wang, Ruoxi, Quinn, Laura, Sanderson, Joseph P., McAlpine, Cheryl, Carozza, Carly, Pimpinella, Eric, Hsu, Susan, Brophy, Francine, Elefant, Erica, Bayer, Paige, Williams, Dennis, Butler, Marcus O., Clarke, Jeffrey M., Gainor, Justin F., Govindan, Ramaswamy, Moreno, Victor, Johnson, Melissa, Tu, Janet, Hong, David S., Blumenschein, George R.
Published in Molecular therapy. Methods & clinical development (13.06.2024)
Published in Molecular therapy. Methods & clinical development (13.06.2024)
Get full text
Journal Article
Phase 1b Study of Motesanib, an Oral Angiogenesis Inhibitor, in Combination with Carboplatin/Paclitaxel and/or Panitumumab for the Treatment of Advanced Non–Small Cell Lung Cancer
BLUMENSCHEIN, George R, RECKAMP, Karen, STEPHENSON, G. Joe, O'ROURKE, Timothy, GLADISH, Gregory, MCGREIVY, Jesse, SUN, Yu-Nien, YINING YE, PARSON, Mandy, SANDLER, Alan
Published in Clinical cancer research (01.01.2010)
Published in Clinical cancer research (01.01.2010)
Get full text
Journal Article
Phase III Trial Comparing Carboplatin, Paclitaxel, and Bexarotene With Carboplatin and Paclitaxel in Chemotherapy-Naïve Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: SPIRIT II
BLUMENSCHEIN, George R, KHURI, Fadlo R, NEGRO-VILAR, Andres, VAN PAWEL, Joachim, GATZEMEIER, Ulrich, MILLER, Wilson H, JOTTE, Robert M, LE TREUT, Jacques, SUN, Show-Li, ZHANG, Jinkun K, DZIEWANOWSKA, Zofia E
Published in Journal of clinical oncology (10.04.2008)
Published in Journal of clinical oncology (10.04.2008)
Get full text
Journal Article
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
Hegde, Aparna, Andreev-Drakhlin, Alexander Y, Roszik, Jason, Huang, Le, Liu, Shuang, Hess, Kenneth, Cabanillas, Maria, Hu, Mimi I, Busaidy, Naifa L, Sherman, Steven I, Dadu, Ramona, Grubbs, Elizabeth G, Ali, Siraj M, Lee, Jessica, Elamin, Yasir Y, Simon, George R, Blumenschein, Jr, George R, Papadimitrakopoulou, Vassiliki A, Hong, David, Meric-Bernstam, Funda, Heymach, John, Subbiah, Vivek
Published in ESMO open (23.10.2020)
Published in ESMO open (23.10.2020)
Get full text
Journal Article
Plasma biomarkers correlating with clinical outcome in a phase II study of sorafenib in advanced NSCLC
Blumenschein, Jr, George R, Reck, Martin, Fossella, Frank, Stewart, David J, Lathia, Chetan, Peña, Carol
Published in Cancer biomarkers : section A of Disease markers (01.01.2011)
Published in Cancer biomarkers : section A of Disease markers (01.01.2011)
Get full text
Journal Article
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
Gomez, Daniel R, Tang, Chad, Zhang, Jianjun, Blumenschein, Jr, George R, Hernandez, Mike, Lee, J Jack, Ye, Rong, Palma, David A, Louie, Alexander V, Camidge, D Ross, Doebele, Robert C, Skoulidis, Ferdinandos, Gaspar, Laurie E, Welsh, James W, Gibbons, Don L, Karam, Jose A, Kavanagh, Brian D, Tsao, Anne S, Sepesi, Boris, Swisher, Stephen G, Heymach, John V
Published in Journal of clinical oncology (20.06.2019)
Published in Journal of clinical oncology (20.06.2019)
Get full text
Journal Article